April 7, 2023 Comments Off on New patent for Optinose Us drug XHANCE Posted in: Patent Added Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optinose Us Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Optinose Us drug XHANCE appeared first on DrugPatentWatch …
April 6, 2023 Comments Off on New patent for Axsome drug AUVELITY Posted in: Patent Added Annual Drug Patent Expirations for AUVELITY Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier. There are one hundred patents…
The post New patent for Axsome drug AUVELITY appeared first on DrugPatentWat…